Trials / Completed
CompletedNCT04018378
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502
An Open-label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Korea University Anam Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The clinical trial aims to assess the pharmacokinetics, safety and tolerability of HIP1502 in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | varenicline tartrate 1mg (HGP1604, R) - varenicline oxalate 1mg (HIP1502, T), RT | varenicline tartrate 1mg (HGP1604) was used as a reference drug and varenicline oxalate 1mg (HIP1502) was used as a test drug. |
| DRUG | varenicline oxalate 1mg (HIP1502, T) - varenicline tartrate 1mg (HGP1604, R), TR | varenicline tartrate 1mg (HGP1604) was used as a reference drug and varenicline oxalate 1mg (HIP1502) was used as a test drug. |
Timeline
- Start date
- 2017-01-06
- Primary completion
- 2017-05-15
- Completion
- 2018-09-17
- First posted
- 2019-07-12
- Last updated
- 2019-07-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04018378. Inclusion in this directory is not an endorsement.